Announced Sat, 1 Aug · 18:12 IST
Neogen Q1FY27 revenue up 34%, EBITDA margin expands 260 bps
Mgmt Guided Margin ImprovementOrder Pipeline DisclosedAnalyst Day Multiyear TargetsCfo Debt Reduction RoadmapInvestor Communications View source PDFExplain this filing
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.1%1-day move
₹2015.10
prior close
₹2055.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.3+0.2-0.2+3.1-0.1+0.6+0.6+7.9+3.0————
Up moveDown movePending
AI summary
Neogen Chemicals posted Q1FY27 consolidated revenue of INR 250 crore, up 34% YoY. EBITDA rose 53% to INR 48 crore with margins expanding 260 bps to 19.3%. PAT jumped 67% to INR 17 crore. Board approved INR 600 crore QIP to de-leverage balance sheet. Raised FY27 standalone revenue guidance to INR 950-1,050 crore. Battery chemicals FY27 target maintained at INR 300 crore. Dahej replacement plant commercial production to start in Q2 FY27.
Likely market impact
Strong quarter with margin expansion and raised guidance. De-leveraging plan and battery ramp-up support positive outlook.